Tudor Investment Corp’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $57K | Sell |
79,455
-2,340
| -3% | -$1.68K | ﹤0.01% | 1487 |
|
2025
Q1 | $120K | Buy |
81,795
+55,729
| +214% | +$81.9K | ﹤0.01% | 1432 |
|
2024
Q4 | $115K | Sell |
26,066
-49,221
| -65% | -$218K | ﹤0.01% | 1434 |
|
2024
Q3 | $310K | Buy |
+75,287
| New | +$310K | ﹤0.01% | 1333 |
|
2024
Q2 | – | Sell |
-64,350
| Closed | -$560K | – | 1727 |
|
2024
Q1 | $560K | Buy |
+64,350
| New | +$560K | ﹤0.01% | 1070 |
|
2022
Q2 | – | Sell |
-172,062
| Closed | -$2.17M | – | 1774 |
|
2022
Q1 | $2.17M | Buy |
172,062
+105,384
| +158% | +$1.33M | 0.05% | 493 |
|
2021
Q4 | $777K | Sell |
66,678
-16,994
| -20% | -$198K | 0.01% | 995 |
|
2021
Q3 | $1.09M | Buy |
+83,672
| New | +$1.09M | 0.02% | 834 |
|
2021
Q2 | – | Sell |
-40,418
| Closed | -$452K | – | 1640 |
|
2021
Q1 | $452K | Buy |
40,418
+28,777
| +247% | +$322K | 0.01% | 1157 |
|
2020
Q4 | $133K | Buy |
+11,641
| New | +$133K | ﹤0.01% | 1239 |
|
2020
Q3 | – | Sell |
-148,488
| Closed | -$1.53M | – | 1404 |
|
2020
Q2 | $1.53M | Buy |
148,488
+81,142
| +120% | +$837K | 0.08% | 326 |
|
2020
Q1 | $680K | Buy |
+67,346
| New | +$680K | 0.06% | 369 |
|
2018
Q4 | – | Sell |
-68,796
| Closed | -$1.06M | – | 1110 |
|
2018
Q3 | $1.06M | Buy |
+68,796
| New | +$1.06M | 0.03% | 428 |
|
2017
Q1 | – | Sell |
-34,237
| Closed | -$438K | – | 1454 |
|
2016
Q4 | $438K | Sell |
34,237
-2,167
| -6% | -$27.7K | 0.01% | 773 |
|
2016
Q3 | $484K | Sell |
36,404
-4,333
| -11% | -$57.6K | 0.01% | 731 |
|
2016
Q2 | $446K | Buy |
40,737
+23,968
| +143% | +$262K | 0.01% | 765 |
|
2016
Q1 | $154K | Sell |
16,769
-14,889
| -47% | -$137K | ﹤0.01% | 1316 |
|
2015
Q4 | $307K | Buy |
31,658
+16,716
| +112% | +$162K | 0.01% | 1067 |
|
2015
Q3 | $130K | Buy |
+14,942
| New | +$130K | ﹤0.01% | 1342 |
|
2013
Q3 | – | Sell |
-24,358
| Closed | -$203K | – | 872 |
|
2013
Q2 | $203K | Buy |
+24,358
| New | +$203K | 0.02% | 713 |
|